JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2401
Arrowhead Research
ARWR
$8.69B
| $5.56M | ﹤0.01% |
303,245
-12,146
| -4% | -$200K |
2018 Q2
3 quarters
|
|
2402
PUT
PepsiCo
PEP
$172B
| $5.55M | ﹤0.01% |
45,300
+35,000
| +340% | +$3.99M |
2018 Q2
3 quarters
|
|
2403
PUT
Bio-Rad Laboratories Class A
BIO
$9.86B
| $5.53M | ﹤0.01% |
+18,100
| New | +$4.88M |
2019 Q1
0 quarters
|
|
|
AKCA
2404
CALL
DELISTED
Akcea Therapeutics Inc
AKCA
| $5.52M | ﹤0.01% |
195,000
+1,500
| +0.8% | +$43.7K |
2018 Q2
3 quarters
|
|
|
CHL
2405
DELISTED
China Mobile Limited
CHL
| $5.52M | ﹤0.01% |
108,213
+100,271
| +1,263% | +$5.24M |
2013 Q2
23 quarters
|
|
|
ARNA
2406
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.51M | ﹤0.01% |
122,842
-7,731
| -6% | -$355K |
2016 Q4
9 quarters
|
|
|
HK
2407
DELISTED
Halcon Resources Corporation
HK
| $5.51M | ﹤0.01% |
4,079,439
+79,710
| +2% | +$129K |
2016 Q3
10 quarters
|
|
|
ZGNX
2408
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $5.5M | ﹤0.01% |
+100,000
| New | +$4.76M |
2019 Q1
0 quarters
|
|
2409
CALL
Murphy Oil
MUR
$5.42B
| $5.49M | ﹤0.01% |
187,500
-298,000
| -61% | -$8.46M |
2018 Q2
3 quarters
|
|
2410
NCR Voyix
VYX
$928M
| $5.49M | ﹤0.01% |
327,922
-35,995
| -10% | -$596K |
2013 Q2
23 quarters
|
|
|
EXTN
2411
DELISTED
Exterran Corporation
EXTN
| $5.49M | ﹤0.01% |
325,630
-115,872
| -26% | -$2.06M |
2015 Q4
13 quarters
|
|
2412
Schwab International Equity ETF
SCHF
$68.3B
| $5.49M | ﹤0.01% |
350,448
-9,992,322
| -97% | -$152M |
2014 Q2
19 quarters
|
|
2413
First Community Bankshares
FCBC
$903M
| $5.48M | ﹤0.01% |
165,420
-53,113
| -24% | -$1.82M |
2013 Q2
23 quarters
|
|
2414
PUT
US Bancorp Series B Preferred Stock
USB.PRH
$731M
| $5.48M | ﹤0.01% |
113,700
-21,400
| -16% | -$413K |
2018 Q2
3 quarters
|
|
2415
Pitney Bowes
PBI
$2.27B
| $5.48M | ﹤0.01% |
797,261
+172,995
| +28% | +$1.2M |
2013 Q2
23 quarters
|
|
2416
Enanta Pharmaceuticals
ENTA
$354M
| $5.46M | ﹤0.01% |
57,181
-20,516
| -26% | -$1.84M |
2016 Q1
12 quarters
|
|
2417
CALL
Regeneron Pharmaceuticals
REGN
$76.1B
| $5.46M | ﹤0.01% |
13,300
-166,700
| -93% | -$68.6M |
2017 Q1
8 quarters
|
|
2418
PUT
Stanley Black & Decker
SWK
$13.6B
| $5.45M | ﹤0.01% |
40,000
-59,800
| -60% | -$7.8M |
2017 Q3
6 quarters
|
|
2419
Columbus McKinnon
CMCO
$491M
| $5.44M | ﹤0.01% |
158,361
-668
| -0.4% | -$23.2K |
2013 Q2
23 quarters
|
|
2420
PUT
XPO
XPO
$21.5B
| $5.44M | ﹤0.01% |
292,609
+136,474
| +87% | +$2.62M |
2018 Q4
1 quarter
|
|
2421
CALL
Invesco S&P SmallCap Low Volatility ETF
XSLV
$236M
| $5.43M | ﹤0.01% |
+240,000
| New | +$11.1M |
2019 Q1
0 quarters
|
|
|
SGEN
2422
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.4M | ﹤0.01% |
73,700
+37,700
| +105% | +$2.68M |
2018 Q4
1 quarter
|
|
|
PPL
2423
CALL
PPL Corp
PPL
$25.4B
| $5.4M | ﹤0.01% |
170,000
-23,100
| -12% | -$718K |
2017 Q1
8 quarters
|
|
|
PPL
2424
PUT
PPL Corp
PPL
$25.4B
| $5.4M | ﹤0.01% |
170,000
-75,900
| -31% | -$2.36M |
2017 Q1
8 quarters
|
|
2425
Cars.com
CARS
$506M
| $5.39M | ﹤0.01% |
236,593
+7,736
| +3% | +$187K |
2017 Q2
7 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.